• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complete Resolution of Bilateral Choroidal Metastases of Cutaneous Melanoma With Combined Targeted Therapy.

作者信息

Szalai Eszter, Csutak Adrienne, Lengyel Zsuzsanna

机构信息

Department of Ophthalmology, University of Pécs Medical School, Pécs, Hungary; and.

Department of Dermatology, Venereology and Oncodermatology, University of Pécs Medical School, Pécs, Hungary.

出版信息

Retina. 2021 Mar 1;41(3):e30-e31. doi: 10.1097/IAE.0000000000003038.

DOI:10.1097/IAE.0000000000003038
PMID:33323905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7889281/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/7889281/e23b839ff8ea/retina-41-e30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/7889281/e23b839ff8ea/retina-41-e30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/7889281/e23b839ff8ea/retina-41-e30-g001.jpg

相似文献

1
Complete Resolution of Bilateral Choroidal Metastases of Cutaneous Melanoma With Combined Targeted Therapy.联合靶向治疗使皮肤黑色素瘤双侧脉络膜转移完全消退
Retina. 2021 Mar 1;41(3):e30-e31. doi: 10.1097/IAE.0000000000003038.
2
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF or BRAF mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial.接受辅助达拉非尼联合曲美替尼治疗的切除后高风险黑色素瘤伴 BRAF 或 BRAF 突变患者的患者报告结局（COMBI-AD）：一项随机、安慰剂对照、III 期临床试验。
Lancet Oncol. 2019 May;20(5):701-710. doi: 10.1016/S1470-2045(18)30940-9. Epub 2019 Mar 27.
3
BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reports.BRAF外显子11突变型黑色素瘤与对BRAF/MEK抑制的敏感性：两例病例报告。
Eur J Cancer. 2019 Nov;121:109-112. doi: 10.1016/j.ejca.2019.08.029. Epub 2019 Sep 27.
4
Discussion.讨论。
J Am Coll Surg. 2015 Apr;220(4):593-5. doi: 10.1016/j.jamcollsurg.2015.01.025.
5
Choroidal Neovascularization in Multifocal Choroiditis after Dabrafenib and Trametinib.达拉非尼和曲美替尼治疗后多灶性脉络膜炎中的脉络膜新生血管形成
Eur J Ophthalmol. 2017 Nov 8;27(6):e184-e186. doi: 10.5301/ejo.5001013.
6
Preliminary results from a prospective trial of preoperative combined BRAF and MEK-targeted therapy in advanced BRAF mutation-positive melanoma.一项针对晚期BRAF突变阳性黑色素瘤术前联合BRAF和MEK靶向治疗的前瞻性试验的初步结果。
J Am Coll Surg. 2015 Apr;220(4):581-93.e1. doi: 10.1016/j.jamcollsurg.2014.12.057. Epub 2015 Jan 30.
7
Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator.一名接受靶向治疗和植入式心脏复律除颤器治疗的转移性黑色素瘤患者的心律失常
Br J Dermatol. 2017 Aug;177(2):584-587. doi: 10.1111/bjd.15447. Epub 2017 Jun 22.
8
Epidermotropic progression of melanoma during therapy with vemurafenib and trametinib.维莫非尼和曲美替尼治疗期间黑色素瘤的表皮趋向性进展
J Am Acad Dermatol. 2016 Oct;75(4):e133-e135. doi: 10.1016/j.jaad.2016.03.006.
9
Successful re-challenge with anti-BRAF and anti-MEK in a patient with symptomatic melanoma flare.一名有症状性黑色素瘤发作的患者成功再次接受抗BRAF和抗MEK治疗。
Eur J Cancer. 2017 Sep;82:25-26. doi: 10.1016/j.ejca.2017.05.039. Epub 2017 Jun 21.
10
ORAL DRUG THERAPY - IMPROVING SURVIVAL IN MALIGNANT MELANOMA.口服药物治疗——提高恶性黑色素瘤的生存率
Ulster Med J. 2018 Jan;87(1):71. Epub 2018 Jan 31.

引用本文的文献

1
Spectrum of presentation of intraocular metastases from cutaneous melanoma in the era of immunotherapy and targeted therapies.免疫治疗和靶向治疗时代皮肤黑色素瘤眼内转移的表现谱
Eye (Lond). 2025 Mar 25. doi: 10.1038/s41433-025-03753-x.
2
Choroidal metastases from thoracic cancer: a retrospective study on clinical characteristics and treatment efficacy.胸段癌脉络膜转移：临床特征与治疗效果的回顾性研究
Front Med (Lausanne). 2025 Feb 26;12:1491278. doi: 10.3389/fmed.2025.1491278. eCollection 2025.